Showing off my Fauci-lie collection

At this point I think people should be trading these like Baseball cards. Its amazing that when its so easy to actually prove these tyrants are lying, lying so often its nearly the only proof that they are actually breathing, people still believe, even near worship them. But then there is that pesky Goebbels quote again. One may suspect that it means a certain percent of the population want, even demand the lie. And a large percentage will die because of it.

Some of these are current Fauci lies, but the interesting ones are when he told truths in the past, exposing what he says now as lies. All of these are revealing in any case.

About Eeyore

Canadian artist and counter-jihad and freedom of speech activist as well as devout Schrödinger's catholic

4 Replies to “Showing off my Fauci-lie collection”

  1. Sorry I don’t have the links, someone sent this to me.
    Wait til you read this.
    I thought I’d do an easy search on SEC.gov for Anthony Fauci. He could be a major stock owner or shareholder. I haven’t looked thru all the filings, but these came up: Enochian Bioscience, Modera Inc. (MRNA on the stock exchange), Organell Regerative Medicine, Inc., Innovation Pharmaceuticals, Inc., Bio N Tech Se, Jaguar Health Inc. Humangen Inc., Cidara Therapeutics Inc. Everbridge Inc. and a few others.

    Just a note about Enochian magic
    Enochian magic is a system of ceremonial magic based on the 16th-century writings of John Dee and Edward Kelley, who wrote that their information, including the revealed Enochian language, was delivered to them directly by various angels. This is a very dangerous occult practice.

    GlobeNewswire
    Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
    Dr. Dybul’s Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences’ Scientific Approach

    July 20, 2021 07:00 ET | Source: Enochian BioSciences, Inc.
    LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Honorable Mark Dybul, M.D. has been named as Chief Executive Officer (CEO).

    Dr. Dybul, who has served as Executive Vice-Chair of the Board of Enochian BioSciences since January 2019, is a globally recognized leader in pandemics. He was a principal architect and ultimately the head of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest international health initiative in history dedicated to a single disease, that achieved historic prevention, care and treatment goals on time and on budget. During his tenure, the program grew from approximately $500 million to $6.5 billion annually. Dr. Dybul went on to transform the Global Fund to Fight AIDS, Tuberculosis and Malaria and, during Dr. Dybul’s four-year tenure, both President Barack Obama and Prime Minister Justin Trudeau hosted funding rounds that raised $25 billion for the Global Fund.

    Dr. Dybul has been deeply involved in the fight against COVID-19. He was the only American appointed to the 15-member Independent Panel for Pandemic Preparedness and Response, mandated by the World Health Assembly and co-chaired by former Liberian President Ellen Johnson Sirleaf and former New Zealand Prime Minister Helen Clark. Dr. Dybul also was a member of the High Level Scientific Advisory Group for the G20’s Global Health Summit focused on COVID-19.

    Under the mentorship of Dr. Anthony Fauci, Dr. Dybul began his career in public health as a researcher at the National Institute of Allergy and Infectious Diseases, ultimately leading a section of Dr. Fauci’s lab and serving as the Assistant Director for Medical Affairs.

    Gregg Alton, Enochian BioSciences’ Board Director and former interim CEO, said, “I have known Mark since he worked closely with Tony Fauci, when I was General Counsel at Gilead Sciences. I watched him lead what was effectively a start-up in the U.S. Government, PEPFAR, and make it one of the most successful public health programs in history. Mark then went on to transform the Global Fund, a public-private partnership, introducing business models for purchasing, supply chain, and many others. He knows how to lead, develop strategy, maintain the teams’ focus and achieve success.”

    “As a long-time researcher, clinician, and leader of large global diseases programs, I am very honored to transition from my current role of Executive Vice-Chair to full-time CEO of Enochian BioSciences,” said Dr. Dybul. “Based in elegantly brilliant science, we have made significant progress in the past 18 months building a deep and wide pipeline with platforms that address major killers including cancer and infectious diseases. The recent acceleration of potential cures for Hepatitis B, HIV and potential inhaled pan-coronavirus, including the cause of COVID-19, and pan-influenza treatment and prevention — makes it an extremely exciting time to become the CEO of Enochian BioSciences.”

    About Enochian BioSciences, Inc.
    Enochian BioSciences, Inc. is a biopharmaceutical company focused on developing innovative platforms for gene-modified cellular and immune therapies to potentially cure and treat deadly diseases. The company’s gene-modified cell and immune therapy platforms can potentially be applied to multiple indications, including HIV/AIDS, Hepatitis B, all Corona and Influenza viruses, and Oncology. For more information, please visit Enochianbio.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*